Peter R. Rossing
Elite in Type 1 Diabetes (T1D)

Peter R. Rossing

Herlev, DK 
Elite in Type 1 Diabetes (T1D)
Herlev, DK 
OverviewLocationsClinical Research

Overview

Peter Rossing practices in Herlev, Denmark. Mr. Rossing is rated as an Elite expert by MediFind in the treatment of Type 1 Diabetes (T1D). His top areas of expertise are Diabetic Nephropathy, Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Tenotomy, and Kidney Transplant.

His clinical research consists of co-authoring 635 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 186 articles in the study of Type 1 Diabetes (T1D).

Gender
Male

Locations

Herlev, Denmark
Other Locations
Copenhagen, Denmark
Gentofte, Denmark
Hellerup, 2900, Denmark
Arhus, Denmark
Aarhus C, Denmark
Hillerod, Denmark
Aarhus N, 8200, Denmark

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Uncontrolled Non-randomised Single Dose Study of Topically Applied Bone Marrow Derived Allogeneic Mesenchymal Stromal Cells (REDDSTAR (ORBCEL-M)) in Patients With Non-healing Neuroischaemic Diabetic Foot Wounds'
Uncontrolled Non-randomised Single Dose Study of Topically Applied Bone Marrow Derived Allogeneic Mesenchymal Stromal Cells (REDDSTAR (ORBCEL-M)) in Patients With Non-healing Neuroischaemic Diabetic Foot Wounds'
Enrollment Status: Terminated
Publish Date: August 19, 2020
Intervention Type: Biological
Study Phase: Phase 1
Effect of Liraglutide on Vascular Inflammation in Type-2 Diabetes: A Randomized, Placebo-controlled, Double-blind, Parallel Clinical PET/CT Trial The Liraflame Trial
Effect of Liraglutide on Vascular Inflammation in Type-2 Diabetes: A Randomized, Placebo-controlled, Double-blind, Parallel Clinical PET/CT Trial The Liraflame Trial
Enrollment Status: Completed
Publish Date: June 11, 2020
Intervention Type: Drug
Study Phase: Phase 4
Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria
Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria
Enrollment Status: Completed
Publish Date: December 21, 2018
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
LeucoPatch in the Management of Hard-to-heal Diabetic Foot Ulcers
LeucoPatch in the Management of Hard-to-heal Diabetic Foot Ulcers
Enrollment Status: Completed
Publish Date: June 25, 2018
Intervention Type: Device, Other
Study Phase: Phase 4
View 3 Less Clinical Trials

635 Total Publications

Comparing CKD populations with T1D and T2D: a perspective based on the FINE-ONE and FIDELITY populations.
Comparing CKD populations with T1D and T2D: a perspective based on the FINE-ONE and FIDELITY populations.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: September 19, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Rossing's expertise for a condition
ConditionClose
View All 12 Advanced Conditions
View All 26 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile